Stocks
GlaxoSmithKline (GSK) OCF US GAAP (year values) |
|||||||||
| 2022 | 2022 | 2022 | 2023 | 2023 | LTM ? | CAGR 5 years ? | |||
| OCF, £ | ? | 7 403 000 000 | 7 403 000 000 | 7 403 000 000 | 6 348 000 000 | 6 348 000 000 | 6 129 000 000 | ||
| Changes by years, y/y, % | -7% | 0% | 0% | -14% | 0% | -5.5% | |||
GlaxoSmithKline. OCF, £
GlaxoSmithKline. OCF, changes, %
GlaxoSmithKline. OCF, sum by quarters, £
GlaxoSmithKline (GSK) OCF US GAAP (quarter values) |
||||||||
| 2024Q2 | 2024Q1 | 2024Q3 | 2024Q2 | 2024Q3 | LTM ? | |||
| OCF, £ | ? | 882 000 000 | 939 000 000 | 2 154 000 000 | 882 000 000 | 2 154 000 000 | 6 129 000 000 | |
| Changes by years, y/y, % | -33% | +1 672% | -3% | -33% | -3% | |||
| Changes by quarters, q/q, % | -70% | +6% | +129% | -59% | +144% | |||
